Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acura Pharmaceuticals Inc (NASDAQ:ACUR)

1.60
Delayed Data
As of 3:59pm ET
 0.0001 / +0.01%
Today’s Change
1.40
Today|||52-Week Range
3.52
-36.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$18.9M

Company Description

Acura Pharmaceuticals, Inc. operates as a pharmaceutical company, which engages in the research, development and commercialization of products intended to address medication abuse and misuse, utilizing its proprietary aversion and impede technologies. It operates its business through the research, development and manufacture of innovative abuse deterrent, orally administered pharmaceutical products. The company was founded in 1935 and is headquartered in Palatine, IL.

Contact Information

Acura Pharmaceuticals, Inc.
616 N. North Court
Palatine Illinois 60067
P:(847) 705-7709
Investor Relations:

Employees

Shareholders

Other institutional14.09%
Mutual fund holders2.00%
Individual stakeholders1.77%

Top Executives

Robert B. JonesPresident, Chief Executive Officer & Director
Peter A. ClemensCFO, Secretary, SVP & Head-Investor Relations
Albert W. BrzeczkoVice President-Technical Affairs
Bob SeiserTreasurer, Vice President & Controller
James F. EmighVice President-Corporate Development